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Introduction
Over the last two decades Newborn Hearing Screening 
(NHS) programs have evolved and are being developed 
in many countries worldwide. As a result, the focus and 
challenges of NHS have shifted from implementing 
programs to creating more efficient and effective 
screening practices (Choo & Meinzen-Derr, 2010; Nelson, 
Bougatsos, & Nygren, 2008; White, Forsman, Eichwald, & 
Muñoz, 2010).
Major challenges for successful and cost-efficient 
screening practices include the need to maintain 
sufficiently low referral and false positive rates. The 
use of repeat screening tests/sessions with automated 
auditory brainstem response (AABR) and/or otoacoustic 
emissions (OAE) technology has proven to be a useful 
approach to achieve these goals (Clemens & Davis, 2001; 
Gravel et al., 2005; Vohr et al., 2001; White et al., 2005). 
A number of well-controlled studies have demonstrated 
that the commonly used two-step/two-technology NHS 
protocols can effectively reduce the overall referral rates to 
≤ 4%  of the total infants screened or even lower for those 
protocols that combine inpatient (IP) and outpatient (OP) 
screens (Thompson et al., 2001). However, while repeated 
automated screens help to enhance specificity by reducing 
false positive results (Clemens & Davis, 2001), they could 
take a toll on the protocol sensitivity and cause more 
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infants with SW_EAR passes were referred for audiological evaluation. The audiological evaluations of 13,044 infants 
who referred (1,907 due to SW_EAR passes) out of the total infant population screened (2,212,107) were analyzed. Of 
the 2,816 infants identified with permanent hearing loss (PHL), 150 (5.3%) were from the group of infants with SW_EAR 
passes. Most of these infants (116/150, 77%) had bilateral PHL, with documented hearing aids in 89 infants and 7 infants 
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infants with hearing loss to pass the screen (an increase 
of false negatives) due to inherent problems of statistical 
artifacts associated with repeated testing (JCIH, 2007, p. 
903).
It is important to systematically evaluate the various factors 
that could impact the overall performance of repeat testing 
NHS protocols. Recent studies by Turner (2013a, 2013b), 
using mathematical modeling and receiver operating 
characteristics (ROC) methodology, identified complex 
interactions between three basic factors that could 
enhance or reduce below optimum the overall performance 
of  NHS protocols using repeat automated screens: (a) 
the accuracy of the screening test/technology in use, (b) 
the internal test correlation measuring the likelihood that 
repeated screens identify the same individuals as positive 
(refer) or negative (pass), and (c) the protocol’s stopping 
criterion by which the results from repeat screens are 
combined to make the final pass/refer decision for the 
infant.
Past studies of NHS have focused on the overall 
efficiency/effectiveness of the most commonly 
implemented protocols (Gravel et al., 2005; White et al., 
2005) or compared the accuracy of the screening method 
(OAE vs. AABR) in use (Norton et al., 2000). However, 
there is limited data available from NHS programs 
regarding the consequences of repeated automated 
screens or the criteria by which the results from multiple 
screens are used to determine the pass/refer outcome 
for an infant. As a result, there is a limited understanding 
of the impact these internal decisions may have on the 
overall performance of the screening protocol being used. 
This knowledge, when available, may provide a rational 
basis for further enhancements of NHS programs.
A key aspect in the implementation of NHS protocols, 
regardless of the technology being used, is how results 
from multiple automated screens are used to make a 
final pass/refer decision for an infant. The Expert Panel 
Recommendations on Newborn Hearing Screening of the 
American Speech-Language-Hearing Association (ASHA, 
2013) state: “…. the infant must pass the screening in both 
ears to be considered a “pass”.  The Recommendations 
also state “… If the newborn fails one ear, both ears must 
be screened during the re-screening”… (ASHA, 2013).
In this context, the interpretation of passing results in both 
ears, which were obtained at a different test session or on 
a different day, poses an interesting problem that needs 
further investigation. There are no agreed-upon criteria for 
deciding how to use ear passes in both ears that were not 
obtained within the same test time or session.
Some Newborn Hearing Screening (NHS) programs 
combine a pass result obtained for the left ear during one 
test session with a pass result obtained for the right ear 
during a different test session to conclude that the infant 
has a bilateral pass for the hearing screen even though 
both ears did not pass during the same test session. 
Unfortunately, it is not known how many infants with PHL 
may be missed by considering non-simultaneous passes 
obtained in each ear during repeated screens (referred to 
in this article as switched ears or SW_EAR passes) as a 
bilateral “pass.” By this practice, an infant who passes only 
one ear (left or right) during a screen session and then 
during a repeat screen performed at a different test time or 
on a different day passes the ear that previously referred, 
would be given a “pass-pass” or screen negative outcome. 
However, there is no systematic research to whether the 
use of such SW_EAR passes may result in infants with 
permanent hearing loss being missed.
Method 
Study Design
A retrospective cross-sectional study compared hearing 
screen results and audiological outcome data collected 
from January 2009 to December 2012 by MEDNAX-
Pediatrix’s nationwide NHS program (PDX_NHS) using 
AABR technology. Out of the total infant population 
screened (2,212,107), infants who received a refer 
status at discharge (13,044) were categorized into two 
groups: (a) those with SW_EAR passes (1,907) and (b) 
those without SW_EAR passes (11,137).  
Inclusion/Exclusion Criteria. During the four years in 
which data were collected for this study, PDX_NHS 
programs referred all infants with SW_EAR passes for 
a complete audiological follow-up. The hearing screen 
data and audiological evaluations were categorized 
into two groups (with and without SW_EAR passes) as 
described below.
Infants with SW_EAR Passes. This group included 
those infants who had non-simultaneous passing results 
which were obtained in each ear during a repeat screen 
performed at a different time or on a different day. The 
“switching” between left ear and right ears passes could 
have occurred during any of the screens performed 
prior to discharge (inpatient) or when recalled as an 
outpatient. These infants would have been considered a 
“pass” (screen negative result) prior to this study. Figure 
1 illustrates an example of an SW_EAR pass result for 
an infant with three repeat inpatient screens.
Infants without SW_EAR Passes. The group included 
those infants who failed one or both ears during the 
final AABR screen performed, prior to discharge as an 
inpatient (IP) and/or when recalled as an outpatient 
(OP), who had no “switching” between left and right ear 
passes during any combination of the screens or test 
sessions performed.
Participants. The study included all infants who 
received a refer status (13,044 in total; 1,907 with 
SW_EAR passes) during the four-year study period 
(2009–2012). The total number of infants screened by 
PDX_NHS programs during this time was 2,212,107, 
which represented 99.9% of all eligible births from 320 
hospitals in 29 states.
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Figure 1. A typical example of SW_EAR hearing screen re-
sults. Three screens were performed, each at a different time 
or test session. Conflicting passing results in each ear (SW_
EAR) were obtained during screen #1 and screen #3. These 
non-simultaneous passes for the Left and Right ear would be 
combined as a Pass-Pass or screen negative outcome for the 
infant if SW_EAR pass results are allowed.
Screening Protocol. The protocol combined IP and 
OP AABR hearing screens (when allowable per state 
specific guidelines) in most facilities. During the study 
period, the PDX_NHS screening protocol limited the 
number of AABR screens that could be performed for 
any infant to a maximum of three repeat screens during 
the IP stage (prior to discharge) and no more than two 
additional screens if recalled for OP testing session.
Equipment. All PDX_NHS programs used AABR as the 
method for screening with equipment manufactured, 
and approved for use, in the USA. However, the specific 
AABR testing device/model varied across hospitals from 
2009–2011 and included ALGO® screeners (models 
ALGO 2E®, ALGO 2EC®, AlGO3®) and Bio-Logic 
ABaer® systems manufactured by Natus Medical Inc., 
as well as, Smart Screener-Plus 2® manufactured 
by Intelligent Hearing Systems. Specifications for 
each product are provided in the Hearing Review 
Products Technology Guides (2012) on the National 
Center for Hearing Assessment and Management 
(NCHAM) website. To facilitate program and operational 
standardization, a conversion to a single manufacturer 
of automated screening devices (Intelligent Hearing 
Systems, Smart Screener-Plus 2®) was initiated 
beginning in 2010 and completed by the end of 2011.
Data Collection. Demographic information of all infants 
screened by PDX_NHS program during the study, each 
infant’s screening results, audiological evaluations, 
and information about use of hearing technology for all 
infants who were referred from the hearing screening 
in each group (with and without SW_EAR passes) 
was maintained in a web-based tracking and database 
management system (Soundata®). Referred infants 
who failed the audiological testing were followed for 
two years to capture as much diagnostic and hearing 
technology data as possible.
Data Audit. The diagnoses/outcomes data maintained 
in Soundata® for the infants who were referred at 
follow-up were audited independently by two authors 
to validate the audiological evaluations data used in 
this study. The authors specifically focused on the 
manual entry of the results from different Audiology/
ENT reports. Different queries were posed to cross-
check the data for inconsistencies in the results and/or 
inconclusive outcomes/diagnoses. Any detected cases 
were reviewed and corrected prior to final data analysis. 
Since a separate diagnostic category for fluctuating or 
temporary hearing loss due to middle ear pathology 
was not available for data categorization during the 
initial stage of the study, a full case-by-case review 
was conducted of all referred infants categorized as 
conductive hearing loss and/or middle ear disorder(s). 
Lastly, all cases in the SW_EAR group with a diagnosis 
of PHL, as well as those documented as receiving 
hearing technology (e.g., cochlear implants and/or 
hearing aids) were reviewed case-by-case and updated/
corrected as needed.
Data Analysis. Upon completion of the data auditing 
process, the audiological outcome data of all referred 
infants in the study sample (with and without SW_EAR 
passes) were analyzed. Data analyses included 
descriptive and nonparametric statistics.
Audiological outcomes data. Infants who were 
referred during screening (with and without SW_EAR) 
were categorized as follows:
Permanent Hearing Loss (PHL). Included infants 
with unilateral or bilateral hearing loss of any of the 
following diagnosis/types: Sensorineural hearing 
losses (SNHL); Auditory Neuropathy Spectrum 
Disorder (ANSD); Permanent Conductive hearing 
loss (PCHL), and mixed hearing loss.
Fluctuating Conductive Hearing Losses (FCHL). 
Included infants whose only hearing loss was 
attributable to temporary or fluctuating unilateral 
or bilateral conductive hearing loss, due to middle 
ear pathology which was evidenced through repeat 
audiological testing and/or following medical 
intervention (e.g., pressure equalization tubes or 
medical treatment).
Inconclusive Diagnosis. Included infants who 
failed follow-up testing with abnormal diagnostic 
tests and/or rescreen results, but had insufficient 
data to reach a definitive audiological diagnosis (i.e., 
type and/or degree of hearing loss in each ear).
No Hearing Loss. Included all infants who passed 
the follow-up audiological testing in both ears. 
Passing results could be obtained with either 
automated screening tests alone (e.g., OAE, AABR) 
or were produced via a complete or incomplete 
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thresholds and/or behavioral testing) as well as 
other audiological tests.
Program Performance Metrics. Appropriate actions 
for SW_EAR results within PDX_NHS program were 
determined by calculating the following metrics of the 
program during the study period and expressed as 
percentages:
Referral Rates: number of refers in each group 
divided by the number of infants screened
Permanent Hearing Loss Rate among Referrals: 
number of infants who had a definitive diagnosis 
of PHL (e.g. sensorineural, conductive, mixed and 
ANSD) unilateral or bilateral in each group, divided 
by the number of infants referred for audiological 
follow-up
No Hearing Loss Rate among Referrals: number 
of refer infants who had passing results during the 
audiological follow-up testing and no temporary 
hearing loss evidenced during the follow-up period 
in each group, divided by the total infants who were 
referred for audiological follow-up
Diagnosed PHL: number of infants who had a 
definitive diagnosis of PHL in each group (e.g., 
SNHL, PCHL, mixed, and ANSD) unilateral or 
bilateral, divided by the total number of infants 
screened
False Positives: number of infants determined 
to have normal hearing who failed the hearing 
screening, divided by the number of infants 
screened
Results 
Figure 2 shows the results for hearing screen data 
and audiological diagnostic evaluation of infants who 
received a refer status in both groups: (a) without SW_
EAR passes and (b) with SW_EAR passes. Seventy-
seven percent of the infants who referred in each 
group during the period of the study (2009–2012) were 
successfully tracked and had Audiology/ENT reports in 
Soundata®.
Most of the infants who were successfully tracked 
had sufficient follow-up data (e.g., Audiology/ENT 
reports, test results, and/or information about use of 
hearing technology) for a definitive diagnosis and could 
be categorized as either: (a) PHL (including SNHL, 
PCHL, mixed or ANSD), (b) FCHL due to transient or 
chronic middle ear pathology, or (c) no hearing loss. 
However, there were a few infants who failed the initial 
diagnostic testing but had insufficient follow-up data for 
determining the nature of the hearing loss and were 
therefore categorized as inconclusive and omitted from 
further analysis (4.7% of those with SW_EAR passes).
Of the 1,907 infants in the group of infants with 
SW_EAR passes (Figure 2), 150 infants (7.9%) were 
diagnosed with PHL including SNHL, ANSD, PCHL, or 
mixed hearing loss. Note that the infants with SW_EAR 
passes constituted 14.6% (1907/13,044) of the total 
infants referred for audiological follow-up. The infants 
with SW_EAR passes who were diagnosed with PHL 
represented 5.3% (150/2,816) of those diagnosed with 
PHL in the population of 2,212,107 infants that were 
screened. Interestingly, in the group of infants with 
SW_EAR passes (1,907 infants) the proportion of PHL 
identified (150/1907, 7.9%) was higher than the PHL 
diagnosed in those infants screened who had no SW_
EAR passes (2,666/2,210,200, 0.12%).
To further validate the audiological diagnosis of PHL, 
data were analyzed for the 183 infants in the group with 
SW_EAR passes who had documented use of hearing 
technology in Soundata® during the follow-up period. 
There were 89 infants diagnosed with PHL in the group 
with SW_EAR passes who were fit with hearing aids 
and 7 infants (6 SNHL, 1 ANSD) who received cochlear 
implants.
The type and degree of hearing loss was reviewed for 
each of the infants diagnosed with PHL in the group 
with SW_EAR passes. Three quarters of these had both 
ears affected (116/150, 77.3%). The severity of PHL 
for the total number of ears affected (N = 266 ears) is 
shown in Figure 3.
Note that about half of the infants’ ears with PHL 
(52.6%, 140/266) had moderate-to-severe or severe-
to-profound hearing loss. Also, 61%  (42/70 ears) of 
the total ears which were classified as mild or mild-to-
moderate PHL were fit with hearing aids. The frequency 
distribution by type of hearing loss diagnosed in both 
groups (with and without SW_EAR passes) is shown in 
Figure 4.
Fluctuating conductive hearing loss due to temporary 
and/or chronic middle ear disorders was more 
frequently diagnosed in the group with SW_EAR passes 
than in the group without SW_EAR passes (Chi square 
= 71.65; p < 0.000). Also, the proportion of PCHL was 
lower in the group with SW_EAR passes compared 
to the group without SW_EAR passes (Chi square 
= 16.59; p < 0.000). Given that PDX_NHS policies 
stipulated that infants with ear atresia should not be 
screened, but should be referred directly for audiological 
follow-up, PCHL secondary to ear atresia/microtia was 
not represented in the group with SW_EAR passes. 
The remaining types of PHL showed similar frequency 
distributions for refer infants with and without SW_EAR 
passes (SNHL: Chi Square = 3.19; p < 0.07; ANSD: Chi 
Square = 1.56; p < 0.21; Mixed: Chi Square  




























































Figure 2. Flowchart summarizing the hearing screen data and audiological diagnostic outcomes of the infants who received a 
refer status in both groups: (a) without SW_EAR and (b) with SW_EAR passes. Lost to Follow-up category includes all refer 
infants that were lost (no audiological follow-up) including those unsuccessfully tracked as well as the parents/physician refus-
als, ineligibles due to medical constraints, etc.
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Figure 3. Severity of permanent hearing loss (PHL) diag-
nosed in infants with SW_EAR passes. (Total number of ears 
affected (N = 266). 
Finally, selected metrics of program performance were 
analyzed for the group of infants without SW_EAR 
passes and for all infants in the sample (see Table 
1). Note that the addition of the group with SW_EAR 
passes allowed the identification of an average of one 
more infant with PHL in every hundred with positive 
screening results (PHL rates increased from 21.7% for 
infants without SW_EAR to 22.9% when infants with 
SW_EAR passes were referred for audiological follow-
up). Also, there was a slight increase in the referral 
rates (from 0.50% to 0.58%, as well as in the proportion 
of infants with no HL (from 34.8% to 42.9%).
Discussion 
The need for systematic evaluation and monitoring 
of NHS program performance has been recognized 
as an important area for clinical research (White, 
Forsman, Eichwald, & Muñoz, 2010, ASHA, 2013). 
This population-based study, conducted within the 
context of PDX_NHS nationwide program provides 
convincing evidence that a significant number of infants 
with permanent hearing loss will be missed if infants 
with SW_EAR passes are not referred for audiological 
evaluation. Furthermore, results constitute strong 
empirical support for the current NHS recommendations 
(ASHA, 2013) that both ears must pass the screening 
for an infant to be screened negative. In addition, it 
supports clarification of the recommendation that both 
ear passes must be obtained during the same test time 
or during the same session.
Evidence from the retrospective analysis of diagnostic 
audiological evaluations collected during a four-year 
period (2009–2012) for 13,044 referred infants (of 


















Switched EarsWithout Switched Ears
Figure 4. Type of permanent hearing loss (PHL) identified in 
infants with and without non-simultaneous passes obtained 
in each ear during different screening sessions (SW_EAR).
Note. ANSD = auditory neuropathy spectrum disorder; FCHL = fluctuating conductive 
hearing loss; MIXED = mixed hearing loss; PCHL = permanent conductive hearing 
loss; SNHL = sensorineural hearing loss.
* Indicates statistical significance (p < 0.05) between infants referred with SW_EAR 
and without SW_EAR.
Table 1  
Impact of referring infants with SW_EAR passes on the 





















Note. Data based on quarterly estimates for each metric calculated across sites 
(320 hospitals in 29 states) during the four years study (2009–2012). HL = hearing 
loss; PHL = permanent hearing loss; PDX_NHS = MEDNEX-Pediatrix newborn 
hearing screening; SW_EAR passes = non-simultaneous passes obtained in each 
ear during different screening sessions.
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total population screened (2,212,107) showed that by 
completing the audiological follow-up on infants with 
SW_EAR passes, PDX_NHS program identified one 
more infant with PHL in every hundred infants who were 
referred from the newborn hearing screening program. 
The infants in group of SW_EAR passes who were 
diagnosed at follow-up with permanent hearing loss 
(150/1,907, 7.3%) represent 5.3% of all infants identified 
with PHL in this sample of 2,212,107 infants who were 
screened. It is also important to note that the program 
maintained very low referral rates (0.58%) even though 
additional infants were being referred.
The hearing loss diagnosed in the group of children 
with SW_EAR passes should be further analyzed. Most 
of these infants diagnosed with PHL (116/150, 77%) 
had bilateral hearing losses and about half of these 
infants’ ears (52%, 140/266) had moderate-to-severe or 
severe-to-profound hearing losses. In addition, a high 
proportion of infants with SW_EAR passes (136/1,907, 
8.5%) were diagnosed with fluctuating conductive 
hearing losses (FCHL) due to middle ear effusion. This 
type of dysfunction could “switch” from one ear to the 
other, and be reflected in non-simultaneous ear passing 
results at different test times. An elevated incidence 
of temporary middle ear dysfunction in the neonatal 
period associated with the development of middle 
ear pathology has been well documented by many 
authors (Doyle, Kong, Strobel, Dallaire, & Ray, 2004; 
Doyle, Rodgers, Fujikawa, & Newman, 2000). The fact 
that the relative proportion of FCHL was significantly 
higher in the infants with SW_EAR passes compared 
to those without SW_EAR passes is consistent with the 
hypothesis that middle ear pathology may be a plausible 
explanation for part of the hearing loss diagnosed in the 
SW_EAR group.
Another possible explanation for the hearing losses 
identified in infants with SW_EAR passes that should 
be analyzed is the problems associated with the use 
of automated screening technology. There are many 
operational factors that may affect screening results 
(e.g., accuracy of earphone placement, artifacts due 
to baby movement, environmental noise, etc.) as well 
as technical issues (e.g., problems of repeat screening 
attempts and lack of standardization of automated 
screening technology). Although these issues have 
been mentioned in the literature (JCIH, 2007; ASHA, 
2013), they have not been adequately explored.
One limitation of this study is that different types of 
AABR equipment were used during the study. Given 
that each type of equipment/manufacturer uses different 
algorithms for determining the pass/refer decision in 
any single screen performed, the likelihood of an infant 
having SW_EAR passes might vary for the different 
devices. This possibility needs to be explored with all 
types of AABR manufactured equipment. Also, the 
possibility that similar results would be obtained with 
OAE equipment needs to be investigated.
Another limitation of the study is the number of repeat 
automated screens that were performed for determining 
the final outcome for an infant. During this period of the 
study, up to five screens (3 IP + 2 OP) were allowed. As 
more screens are performed, the statistical problems of 
sequential testing (Stürzebecher, Cebulla, & Elberling, 
2005; Stürzebecher & Cebulla, 2013) may increase the 
probability of falsely passing PHL, but this needs to be 
investigated.
The implications of this study for clinical practice are 
important. Current best practice guidelines state that 
both ears should pass for an infant to pass the screen 
(ASHA, 2013). Also, the recommendations state that 
both ears must be tested during re-screening. The 
empirical data provided in this study supports the above 
recommendations and indicates that both ears should 
pass within the same screening session for an infant 
to be considered a pass (screen negative outcome). 
The fact that PHL, mostly bilateral and of significant 
magnitude, was diagnosed in this group, suggests that 
infants with non-simultaneous ear passes should be 
referred and tracked for audiological follow-up with the 
same urgency as repeat “non-switching” unilateral or 
bilateral refers.
The results of this study also demand refocused 
attention on how parents are counseled regarding 
SW_EAR results by screeners, pediatricians, and 
audiologists. Providers should not suggest that because 
a pass result was obtained for both ears, albeit at 
different times, that the diagnostic evaluation is likely 
to result in a conclusion that the infant has normal 
hearing. Indeed only 55.6% of the 1,907 infants who 
had SW_EAR passes were determined to have normal 
hearing, with the remainder being diagnosed with 
PHL (7.9%) or conductive hearing loss (CHL; 8.5%), 
having inconclusive results (4.7%), or not returning 
for the audiological evaluation (23.3%). These data 
suggest that if providers minimize the importance of 
parents completing diagnostic follow-up testing, there 
is a real possibility of missing infants with permanent 
and conductive hearing loss with a consequential 
detrimental effect for infant development (Yoshinaga-
Itano, Coulter, & Thomson, 2001).
Conclusion 
This retrospective study of 2,212,107 screened 
infants, 1,907 of whom had SW_EAR passes, provides 
evidence for eliminating the practice of passing infants 
by combining “switched ear” passes from repeat 
screens and therefore missing potential permanent 
hearing loss.  Results support the current ASHA best 
practice recommendation which requires both ears 
to pass the screening for an infant to be screened 
negative with the added specification that both ear 
passes should be obtained within the same screening 
session. Furthermore, all hearing health care providers 
55
involved in clinical follow-up care of refer infants should 
be cautious about concluding that an infant has normal 
hearing based on non-simultaneous passes on each ear 
from repeat screens.
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